Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Tfct Nib OD 11mg Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Tofacitinib (11mg)

Overview Tfct Nib OD 11mg Tablet

Eleven-milligram Nib OD tablets are indicated for managing moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. They alleviate joint pain, tenderness, and swelling by suppressing inflammation, and help retard the progression of bone and joint deterioration. Prescription may be solo or adjunctive, with administration possible with or without food, ideally at a consistent time daily. Dosage is individualized, factoring in your health status and other medications. Strict adherence to your physician's instructions is vital; abrupt cessation is discouraged as it could exacerbate your condition. Common side effects encompass upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events include blood clots and gastrointestinal perforations, necessitating immediate medical attention. Report any concerns regarding side effects to your doctor. Pre-treatment blood work may be required, and initiation is contraindicated with active infections. Prior to commencing therapy, disclose any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. This medication increases susceptibility to infections, potentially worsening existing ones; avoid contact with contagious individuals (e.g., those with influenza, measles, or chickenpox). This medication is unsuitable for individuals under 18 and should be avoided during pregnancy or breastfeeding unless deemed medically necessary by your doctor. Regular monitoring by your physician may be necessary.

Uses of Tfct Nib OD 11mg Tablet

Managing rheumatoid, psoriatic, and ankylosing spondylitis arthritis, plus ulcerative colitis.

Major Benefits of Tfct Nib OD 11mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 11mg Tfct Nib OD Tablet can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Tfct Nib OD 11mg Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tfct Nib OD 11mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 11mg Tfct Nib OD Tablet can be consumed with or without food; however, consistent daily timing is recommended.

How Tfct Nib OD 11mg Tablet works:

One-eleven milligram Tfct Nib tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This consequently reduces immune system activation and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

Concurrent alcohol use with Tfct Nib OD 11mg Tablets poses no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tfct Nib OD 11mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tfct Nib OD 11mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by taking one 11mg tablet of Tfct Nib OD.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Tfct Nib OD 11mg Tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Tfct Nib OD 11mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.

What if you forget to take Tfct Nib OD 11mg Tablet :

Should you forget a dose of Tfct Nib OD 11mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tfct Nib OD 11mg Tablet

LabelValue
Chemical Type Pyrrolopyrimidine Compound
Developing Habits No.
Treatment Category Pain Relief Medications
Action Class JAK inhibitors

FAQs on Tfct Nib OD 11mg Tablet

Tell your doctor about any liver problems before taking Tfct Nib OD 11mg Tablet, as it can sometimes raise liver enzyme levels. Your liver function should be checked before starting treatment. While this medication can be used in patients with mild to moderate liver impairment, it's contraindicated in those with severe impairment.
Taking Tfct Nib OD 11mg Tablets may raise your risk of certain cancers, such as lymphoma and skin cancer, due to its effects on the immune system. Tell your doctor if you have or have had any cancer.
Tfct Nib OD 11mg Tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. This medication is used when prior treatments proved ineffective or unsuitable. It may also be prescribed earlier if initial drug therapies fail. Tfct Nib OD 11mg Tablets can be administered alone or in conjunction with other medications, including methotrexate.
You may notice improvement from Tfct Nib OD 11mg Tablet within 2 to 8 weeks, though full benefits may take 3 to 6 months.
Before and during treatment with Tfct Nib OD 11mg Tablet, blood tests may be necessary to monitor for anemia, neutropenia or lymphopenia, high cholesterol, and elevated liver enzymes. These tests help ensure the medication isn't causing adverse effects. Your doctor may also recommend a tuberculosis test beforehand, as Tfct Nib OD 11mg Tablet could worsen an existing infection.
Tfct Nib OD 11mg Tablets suppress the immune system, increasing susceptibility to serious infections, including tuberculosis and potentially life-threatening fungal, bacterial, or viral infections. Hospital treatment is recommended for such infections.
Combining tocilizumab and Tfct Nib OD 11mg Tablet is unsafe. Tfct Nib OD 11mg Tablet's immune-suppressing effects mean it shouldn't be used with other such medications. Concurrent use significantly raises infection risk and potential complications.
Tfct Nib OD 11mg Tablet
751
MRP 869
13% off